PODD
Insulet Corporation
NASDAQ: PODD · HEALTHCARE · MEDICAL DEVICES
$148.93
-0.60% today
Updated 2026-10-28
Market cap
$9.79B
P/E ratio
26.42
P/S ratio
3.21x
EPS (TTM)
$5.34
Dividend yield
—
52W range
$126 – $355
Volume
1.6M
Insulet Corporation (PODD) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$148.93
12-Month target
$104.44
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.1B | $1.3B | $1.7B | $2.1B | $2.7B | $3.2B | $3.9B | $4.7B | $5.6B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 20.00% (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 12.30%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.